US Stock MarketDetailed Quotes

QNRX Quoin Pharmaceuticals

Watchlist
  • 0.7200
  • -0.0131-1.79%
Close Apr 18 16:00 ET
  • 0.7188
  • -0.0012-0.17%
Post 18:04 ET
2.65MMarket Cap-74P/E (TTM)

About Quoin Pharmaceuticals Company

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Company Profile

SymbolQNRX
Company NameQuoin Pharmaceuticals
Listing DateJul 29, 2016
Issue Price6.50
Founded2018
CEOMr. Michael Myers
MarketNASDAQ
Employees4
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address42127 Pleasant Forest Court
CityAshburn
ProvinceVirginia
CountryUnited States of America
Zip Code20148-7349
Phone1-703-980-4182
Websitehttp://www.quoinpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael Myers
  • Chairman of the Board and Chief Executive Officer
  • 1.97M
  • Denise Carter
  • Director and Chief Operating Officer
  • 1.81M
  • Gordon Dunn
  • Chief Financial Officer and Principal Accounting Officer
  • 1.45M
  • Michael Sember
  • Independent Director
  • 228.57K
  • Dr. Dennis H. Langer, J.D.,M.D.
  • Independent Director
  • 253.57K
  • Natalie Leong
  • Independent Director
  • 243.57K
  • Joseph P. Cooper
  • Independent Director
  • 233.57K
  • Anthony James Culverwell
  • Independent Director
  • 238.57K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg